TI
BIO icon

tru Independence’s Bio-Rad Laboratories Class A BIO Stock Holding History

tru Independence’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10
Closed -$4K – 374
2020
Q2 		$4K Buy
+10
New +$4.41K ﹤0.01% 721
2020
Q1 		– Sell
-104,065
Closed -$3.51M – 731
2019
Q4 		$3.51M Buy
+104,065
New +$36.7M 0.5% 65

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

tru Independence's BIO Position: Q3 2020 in Review

tru Independence sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 10 shares — an estimated $4K sold.

tru Independence first reported a position in BIO in Q4 2019 and held it in 2 quarters. The position peaked at $3.51M in Q4 2019. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • tru Independence reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • tru Independence sold 10 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $4K.
  • tru Independence first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 2 quarters.
  • tru Independence's Bio-Rad Laboratories Class A position peaked at $3.51M in Q4 2019.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.